S617-0134 Screening compound: N~1~-[(3S,4S)-4-(hydroxymethyl)-1-(1H-indol-4-ylcarbonyl)hexahydro-3-pyridinyl]-1-cyclopropanecarboxamide

S617-0134 Screening compound: N~1~-[(3S,4S)-4-(hydroxymethyl)-1-(1H-indol-4-ylcarbonyl)hexahydro-3-pyridinyl]-1-cyclopropanecarboxamide
S617-0134 Screening compound: N~1~-[(3S,4S)-4-(hydroxymethyl)-1-(1H-indol-4-ylcarbonyl)hexahydro-3-pyridinyl]-1-cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S617-0134
N~1~-[(3S,4S)-4-(hydroxymethyl)-1-(1H-indol-4-ylcarbonyl)hexahydro-3-pyridinyl]-1-cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S617-0134

Molecular Formula

C19H23N3O3 (C19 H23 N3 O3)

Compound Name

N~1~-[(3S,4S)-4-(hydroxymethyl)-1-(1H-indol-4-ylcarbonyl)hexahydro-3-pyridinyl]-1-cyclopropanecarboxamide

IUPAC name

N-[(3S4S)-4-(hydroxymethyl)-1-(1H-indole-4-carbonyl)piperidin-3-yl]cyclopropanecarboxamide

SMILES

OC[C@H](CCN(C1)C(c2c(cc[nH]3)c3ccc2)=O)[C@H]1NC(C1CC1)=O

InChI

InChI=1S/C19H23N3O3/c23-11-13-7-9-22(10-17(13)21-18(24)12-4-5-12)19(25)15-2-1-3-16-14(15)6-8-20-16/h1-3,6,8,12-13,17,20,23H,4-5,7,9-11H2,(H,21,24)/t13-,17+/m1/s1

InChI Key

WYKHUIUIGKTZIO-DYVFJYSZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

341.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.014

Distribution Coefficient, logD

1.014

Water Solubility, LogSw

-2.04

Polar Surface Area

68.576

Acid Dissociation Constant (pKa)

15.55

Base Dissociation Constant (pKb)

0.54

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

47.37

S617-0134 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S617-0134 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S617-0134?
Check Price and Availability of S617-0134, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S617-0134 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S617-0134
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S617-0134
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S617-0134 available by request